You have accessJournal of UrologyProstate Cancer: Detection and Screening II1 Apr 2015MP60-11 SHOULD A NORMAL MULTIPARAMETRIC MRI PRECLUDE PROSTATE BIOPSY? Christopher Filson, Daniel Margolis, Jiaoti Huang, Shyam Natarajan, Patricia Lieu, Frederick Dorey, and Leonard Marks Christopher FilsonChristopher Filson More articles by this author , Daniel MargolisDaniel Margolis More articles by this author , Jiaoti HuangJiaoti Huang More articles by this author , Shyam NatarajanShyam Natarajan More articles by this author , Patricia LieuPatricia Lieu More articles by this author , Frederick DoreyFrederick Dorey More articles by this author , and Leonard MarksLeonard Marks More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2015.02.2213AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookTwitterLinked InEmail INTRODUCTION AND OBJECTIVES Multi-parametric magnetic resonance imaging (mpMRI) may identify regions of the prostate suspicious for cancer (CaP), allowing targeted biopsy. However, the negative predictive value (NPV) of mpMRI for prostate cancer detection is not yet known. To determine the NPV of mpMRI, we determined the frequency of CaP detection by systematic mapping biopsy in men whose mpMRI showed no suspicious regions. METHODS In a prospective, IRB-approved protocol, 1044 men underwent mpMRI and Artemis-biopsy (2009 – 2014). Of these, we report on 244 (mean age = 64±7.6 yrs, median PSA = 4.9 ng/ml, mean prostate volume = 54±30 cc) whose mpMRI showed no suspicious regions, and who underwent 12-core template-based mapping biopsy. Among this cohort, 74 were undergoing first biopsy, 54 had ≥ 1 prior negative biopsies, and 116 had a prior positive biopsy. The mpMRI used a 3T trans-abdominal coil, was performed within 3 months of fusion biopsy, and deemed negative by an expert reader (DM). Biopsy sites were identified and sampled by an single operator (LM) using the Artemis system for guidance. Cores were submitted separately and read by a single uropathologist (JH). We performed chi-square testing and fit logistic regression models to evaluate the relationship between biopsy findings and clinical characteristics. RESULTS Overall, 113 patients with no region of interest on mpMRI (47%) were found to have GS ≥ 6 CaP upon mapping biopsy (Figure), which was more likely among patients with smaller prostates and prior positive biopsies (all p<0.05). Furthermore, 38 patients (16%) had GS ≥ 7 CaP; in these men PSA was directly related to finding of CaP (p=0.02). Age, race, and CaP location within the organ were not related in either group. The NPV of mpMRI for GS ≥ 6 and GS ≥ 7 CaP was 53% and 84%, respectively. CONCLUSIONS 16% of men with GS ≥ 7 CaP would have gone undiagnosed, if a normal mpMRI precluded biopsy. The present data suggest that, if otherwise clinically indicated, prostate biopsy should be performed even if the mpMRI shows no target. © 2015 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 193Issue 4SApril 2015Page: e742 Advertisement Copyright & Permissions© 2015 by American Urological Association Education and Research, Inc.MetricsAuthor Information Christopher Filson More articles by this author Daniel Margolis More articles by this author Jiaoti Huang More articles by this author Shyam Natarajan More articles by this author Patricia Lieu More articles by this author Frederick Dorey More articles by this author Leonard Marks More articles by this author Expand All Advertisement Advertisement PDF downloadLoading ...